Allena Pharmaceuticals, Inc.
USD0.07
+0.00 (+3.16%)
CEO
Louis Brenner
IPO Date
2017-11-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.06
Prev. Close
$0.07
Day Low
Day High
$0.15
Volume
252.31M
Allena Pharmaceuticals to Host Key Opinion Leader Webinar Focused on ALLN-346 for the Treatment of Gout in Patients with Chronic Kidney Disease
Top Penny Stocks For Your May Watchlist? Check These 5 Out
Moving Average Crossover Alert: Allena Pharmaceuticals (ALNA)
Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in March
Has Allena Pharmaceuticals (ALNA) Outpaced Other Medical Stocks This Year?